JNJ
insider transactionsJOHNSON & JOHNSON — buys & sells by directors, officers and 10% owners A shareholder owning more than 10% of the company. Must report trades, but usually a weaker signal than an officer or director. (SEC Form 4).
Net shares · 90d
-10.0K
0 buy · 10.0K sell
Net value · 90d
-$2.4M
$0 in · $2.4M out
Sentiment · 90d
Net selling
0% buying · 100% selling
Open-market trades · 90d
1
0 buy · 10.0K sell
Net buy / sell volume
Not enough data to chart yet.
Tap or hover the chart for daily net volume. Green = net buying, red = net selling.
All transactions
-
Exercise·M
EVP, Chief TO and Risk Officer
$0
10.0K sh
Own +44%
-
Sell·S
EVP, Chief TO and Risk Officer
$2.4M
10.0K sh · $241.15
Own -8%
-
Exercise·M
EVP, Chief TO and Risk Officer
$1.2M
10.0K sh · $115.67
Own +9%
-
Grant·A
Director
$37.5K
161 sh · $232.79
Own +3%
-
Grant·A
Director
$31.2K
134 sh · $232.79
Own +6%
-
Grant·A
Director
$50.0K
215 sh · $232.79
Own +1%
-
Exercise·M
EVP, Innovative Medicine, R&D
$0
25.3K sh
Own New
-
Other·F
EVP, Innovative Medicine, R&D
$2.5M
11.0K sh · $229.85
Own -31%
-
Exercise·M
EVP, Innovative Medicine, R&D
$0
25.3K sh
Own +237%
-
Grant·A
Director
$0
975 sh
Own +19%
-
Grant·A
Director
$0
975 sh
Own +14%
-
Grant·A
Director
$0
975 sh
Own +9%
-
Grant·A
Director
$0
1.7K sh
Own +371%
-
Grant·A
Director
$0
1.5K sh
Own New
-
Grant·A
Director
$0
975 sh
Own +5%
-
Grant·A
Director
$0
975 sh
Own +12%
-
Grant·A
Director
$0
975 sh
Own +22%
-
Grant·A
Director
$0
975 sh
Own +7%
| Date▾ | Insider | Type | Shares | Value |
|---|---|---|---|---|
| Jun 11, 2026 | Kathryn E Wengel | Exercise M | 10.0K | $0 |
| Jun 11, 2026 | Kathryn E Wengel | Sell S | 10.0K | $2.4M |
| Jun 11, 2026 | Kathryn E Wengel | Exercise M | 10.0K | $1.2M |
| Jun 9, 2026 | Eugene A. Woods | Grant A | 161 | $37.5K |
| Jun 9, 2026 | Daniel E Pinto | Grant A | 134 | $31.2K |
| Jun 9, 2026 | Marillyn A Hewson | Grant A | 215 | $50.0K |
| May 1, 2026 | REED JOHN C | Exercise M | 25.3K | $0 |
| May 1, 2026 | REED JOHN C | Other F | 11.0K | $2.5M |
| May 1, 2026 | REED JOHN C | Exercise M | 25.3K | $0 |
| Apr 23, 2026 | Eugene A. Woods | Grant A | 975 | $0 |
| Apr 23, 2026 | Nadja West | Grant A | 975 | $0 |
| Apr 23, 2026 | Mark A Weinberger | Grant A | 975 | $0 |
| Apr 23, 2026 | Daniel E Pinto | Grant A | 1.7K | $0 |
| Apr 23, 2026 | John G Morikis | Grant A | 1.5K | $0 |
| Apr 23, 2026 | Mark B. Mcclellan | Grant A | 975 | $0 |
| Apr 23, 2026 | Hubert Joly | Grant A | 975 | $0 |
| Apr 23, 2026 | Paula A Johnson | Grant A | 975 | $0 |
| Apr 23, 2026 | Marillyn A Hewson | Grant A | 975 | $0 |
About JNJ insider trading
This page tracks insider transactions for JOHNSON & JOHNSON (JNJ) reported to the U.S. Securities and Exchange Commission on Form 4. Corporate insiders — directors, executive officers and beneficial owners of more than 10% of the stock — must disclose their trades within two business days. Open-market purchases (code P) and sales (code S) made at the insider's discretion are the most-watched opportunistic signals, while awards (A), option exercises (M) and tax-withholding (F) reflect compensation rather than conviction. Trades marked 10b5-1 were made under a pre-arranged plan and are considered routine. A cluster buy — several insiders buying within a short window — is historically a stronger bullish indicator than any single trade.